Integrin αM Inhibitors

Common Integrin αM Inhibitors include, but are not limited to PHA 767491 Dihydrochloride Salt CAS 845714-00-3, BIRT 377 CAS 213211-10-0, PHA 767491 Dihydrochloride Salt CAS 845714-00-3, BIRT 377 CAS 213211-10-0 and PHA 767491 Dihydrochloride Salt CAS 845714-00-3.

Integrin αM inhibitors represent a distinct chemical class of compounds that target the Integrin αM subunit, a member of the integrin family of cell adhesion receptors. Integrins are transmembrane proteins that play a critical role in mediating cell-cell and cell-extracellular matrix interactions. Integrin αM, also known as CD11b, forms a heterodimeric complex with the β2 subunit (CD18) to create the αMβ2 integrin, also called Mac-1 or CR3. This integrin is primarily expressed on the surface of leukocytes, including neutrophils, monocytes, and macrophages. Integrin αM is involved in various cellular processes, such as leukocyte adhesion, migration, phagocytosis, and immune responses. It plays a crucial role in mediating the recruitment of leukocytes to sites of inflammation and infection, promoting their attachment to endothelial cells, and facilitating their transmigration into tissues. Additionally, Integrin αM is implicated in the modulation of inflammatory signaling pathways, which can influence immune cell activation and the release of inflammatory mediators.

Integrin αM inhibitors are designed to specifically interact with the αM subunit, disrupting the formation of functional αMβ2 integrins on the cell surface. By inhibiting the function of Integrin αM, these compounds can alter leukocyte adhesion and migration processes, affecting immune responses and inflammatory reactions. Scientists are actively studying the pharmacological properties and mechanisms of action of Integrin αM inhibitors to gain insights into their effects on cellular behavior and immune system regulation.